Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| R01NR019512 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute of Nursing Research (NINR) | NIH |
Not provided
Not provided
Not provided
Not provided
By combining two strategies (i.e., peer navigation and mHealth) into a complete, culturally compatible, bilingual intervention to increase the use of needed HIV, STI, and HCV prevention and care services among racially/ethnically diverse GBMSM and transgender women in rural Appalachia.
Study Investigators anticipate that participants in the intervention group, relative to counterparts in the delayed-intervention group, will demonstrate increased HIV, STI, and HCV testing.
This CBPR study will advance prevention science and practice through testing an innovative intervention to promote and support the use of needed HIV, STI, and HCV prevention and care services among GBMSM and transgender women; and developing priorities and recommendations to improve their health that will be disseminated to inform public health practice, research, and policy. By integrating peer navigation and mHealth strategies, the proposed study provides a unique opportunity to improve health among vulnerable, hidden, and neglected populations living in rural Appalachia. Findings from this research may inform strategies and approaches to address other health disparities in other rural populations.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| intervention group | Active Comparator | 7 community health leaders; 56 social network members |
|
| delayed-intervention | Active Comparator | 7 community health leaders; 56 social network members |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Peer Navigation | Behavioral | First, as health advisors, community health leaders will raise awareness of HIV, STIs, and HCV and local prevention and care services and help social network members access services. Thus, the community health leader will describe to the process for HCV testing, and how providers are required to maintain confidentiality. As opinion leaders, community health leaders will reframe health-compromising and bolster health-promoting norms and expectations about testing and use of other prevention and care services. Each community health leader will also conduct formal in-person group activities with their social network members. Our partnership decided that each community health leader will also hold at least 4 formal group sessions during the 12 months of intervention |
| Measure | Description | Time Frame |
|---|---|---|
| Number of participants who have Human Immunodeficiency Virus (HIV) testing | baseline | |
| Number of participants who have Sexually Transmitted Infection (STI) testing | baseline | |
| Number of participants who have Hepatitis C Virus (HCV) testing | baseline | |
| Number of participants who have HIV testing | immediate post-intervention (12 months post-baseline) | |
| Number of participants who have STI testing | immediate post-intervention (12 months post-baseline) | |
| Number of participants who have HCV testing | immediate post-intervention (12 months post-baseline) | |
| Number of participants who have HIV testing | 12-month follow-up (24 months post-baseline) | |
| Number of participants who have STI testing | 12-month follow-up (24 months post-baseline) | |
| Number of participants who have HCV testing | 12-month follow-up (24 months post-baseline) |
| Measure | Description | Time Frame |
|---|---|---|
| Number of participants who use prevention--Pre-exposure prophylaxis (PrEP) | baseline, immediate post-intervention (12 months post-baseline), and 12-month follow-up (24 months post-baseline). | |
| Number of participants who use prevention--syringe services |
Not provided
Inclusion Criteria:
GBMSM (Gay, Bisexual, Men who have sex with men)
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Scott D. Rhodes, Ph.D, MPH | Contact | 336-713-5080 | scott.rhodes@wfusm.edu |
| Name | Affiliation | Role |
|---|---|---|
| Scott D. Rhodes, Ph.D, MPH | Wake Forest University Health Sciences | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Wake Forest University Health Sciences | Recruiting | Winston-Salem | North Carolina | 27157 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000163 | Acquired Immunodeficiency Syndrome |
| D012749 | Sexually Transmitted Diseases |
| ID | Term |
|---|---|
| D015658 | HIV Infections |
| D000086982 | Blood-Borne Infections |
| D003141 | Communicable Diseases |
| D007239 | Infections |
Not provided
Not provided
| ID | Term |
|---|---|
| D017216 | Telemedicine |
| ID | Term |
|---|---|
| D003695 | Delivery of Health Care |
| D010346 | Patient Care Management |
| D006298 | Health Services Administration |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| mHealth | Behavioral | In addition to in-person individual and group activities, community health leaders will use mHealth platforms preferred by each social network member (i.e., Facebook , Instagram, testing, and/or GPS-based mobile apps) to communicate with them during the intervention. They will use social media to plan activities and to support use of needed prevention and care services. For example, when planning a group activity (described above), the community health leader will use social media to remind social network members about the activity and help them problem solve barriers to attending. A community health leader and social network member may also communicate "in-real-time" via social media about the process of participating in a syringe services program or accessing PrEP. |
|
| baseline, immediate post-intervention (12 months post-baseline), and 12-month follow-up (24 months post-baseline). |
| Number of participants who use HIV care services | Measured through self-report and medical chart abstraction | baseline, immediate post-intervention (12 months post-baseline), and 12-month follow-up (24 months post-baseline). |
| Number of participants who use STI treatment services | Measured through self-report and medical chart abstraction | baseline, immediate post-intervention (12 months post-baseline), and 12-month follow-up (24 months post-baseline). |
| Number of participants who use HCV treatment services | Measured through self-report and medical chart abstraction | baseline, immediate post-intervention (12 months post-baseline), and 12-month follow-up (24 months post-baseline). |
| Number of participants who use gender-affirming care services | Measured through self-report and medical chart abstraction | baseline, immediate post-intervention (12 months post-baseline), and 12-month follow-up (24 months post-baseline). |
| D015229 |
| Sexually Transmitted Diseases, Viral |
| D016180 | Lentivirus Infections |
| D012192 | Retroviridae Infections |
| D012327 | RNA Virus Infections |
| D014777 | Virus Diseases |
| D012897 | Slow Virus Diseases |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D007153 | Immunologic Deficiency Syndromes |
| D007154 | Immune System Diseases |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |